Literature DB >> 30067406

Meeting the Challenge: Hepatitis C Virus and HIV Care Experiences Among HIV Specialty Providers.

Leah M Adams1, Benjamin Balderson2, Bruce J Packett3.   

Abstract

Hepatitis C virus (HCV) is frequently comorbid with HIV infection and is independently associated with a significant increase in all-cause mortality among HIV-positive adults. HIV specialists' role and experiences in treating HCV has been understudied, especially among those providers who actively treat patients with HCV. We conducted a brief online survey of HIV specialists (physicians, nurse practitioners, physician assistants, and prescribing pharmacists) who treat patients with HCV to examine their experiences with treating these patients (HCV monoinfected, HIV/HCV coinfected). Survey questions assessed providers' annual caseloads, barriers, and facilitators to providing HCV care, likelihood of providing HCV treatment to patients with various risk factors, and the extent to which their HCV screening practices aligned with CDC (Centers for Disease Control) guidelines for patients from various risk groups. A total of 168 HIV care providers were included in analyses. Nearly all specialists surveyed actively treated HIV/HCV coinfected patients, while fewer treated any HCV monoinfected patients. Providers' screening practices typically aligned with guidelines across patient groups, but their likelihood of prescribing HCV treatment to patients varied across patients' risk profiles. Providers endorsed high levels of knowledge to treat HCV-infected patients, but highlighted key barriers to providing optimal care. Given that HIV specialists are an active group treating patients with HCV, they may benefit from specialized guidance on managing HCV in patients with complex histories, including comorbid HIV infection.

Entities:  

Keywords:  HIV/AIDS; healthcare survey; hepatitis C virus (HCV); patient care

Mesh:

Year:  2018        PMID: 30067406     DOI: 10.1089/apc.2018.0006

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  3 in total

1.  Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs): A Qualitative Analysis with Persons with HIV/HCV Co-infection Who Delay or Refuse Treatment.

Authors:  Sarah Brothers; Elizabeth DiDomizio; Lisa Nichols; Ralph Brooks; Merceditas Villanueva
Journal:  AIDS Behav       Date:  2022-07-01

2.  Rapid Visual Detection of Hepatitis C Virus Using Reverse Transcription Recombinase-Aided Amplification-Lateral Flow Dipstick.

Authors:  Haili Wang; Yuhang Zhang; Jingming Zhou; Ming Li; Yumei Chen; Yankai Liu; Hongliang Liu; Peiyang Ding; Chao Liang; Xifang Zhu; Ying Zhang; Cheng Xin; Gaiping Zhang; Aiping Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-02-17       Impact factor: 5.293

3.  Direct-Acting Antiviral Hepatitis C Treatment Cascade and Barriers to Treatment Initiation Among US Men and Women With and Without HIV.

Authors:  Danielle F Haley; Andrew Edmonds; Catalina Ramirez; Audrey L French; Phyllis Tien; Chloe L Thio; Mallory D Witt; Eric C Seaberg; Michael W Plankey; Mardge H Cohen; Adaora A Adimora
Journal:  J Infect Dis       Date:  2021-06-15       Impact factor: 7.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.